Dwight Moxie, SVP, GC & Secretary at Revance Therapeutics, Inc. (RVNC), sold 58,706 shares at $17.06 ($1.0M) on 2023-09-06, disclosed to the SEC on 2023-09-07.
Scheduled sale ($1.0M) by SVP, GC & Secretary under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $17.81 | 23,853 | $425K | 41.0% |
| 2 | $17.81 | 23,853 | $425K | 41.0% |
| 3 | $17.06 | 11,000 | $188K | 18.1% |
| Total | $17.67 avg | 58,706 | $1.0M | 100% |
| Filing → |
| RVNC | SELL | 2023-03-09 | $1.2M | — | Filing → |
| RVNC | SELL | 2022-09-16 | $298K | — | Filing → |
| RVNC | SELL | 2021-09-28 | $50K | — | Filing → |